KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) Revenue (2016 - 2025)

Historic Revenue for Global Medical REIT (GMRE) over the last 12 years, with Q3 2025 value amounting to $37.2 million.

  • Global Medical REIT's Revenue rose 865.34% to $37.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.0 million, marking a year-over-year increase of 614.13%. This contributed to the annual value of $138.8 million for FY2024, which is 160.87% down from last year.
  • As of Q3 2025, Global Medical REIT's Revenue stood at $37.2 million, which was up 865.34% from $38.0 million recorded in Q2 2025.
  • Global Medical REIT's Revenue's 5-year high stood at $38.0 million during Q2 2025, with a 5-year trough of $27.3 million in Q1 2021.
  • In the last 5 years, Global Medical REIT's Revenue had a median value of $34.6 million in 2025 and averaged $33.8 million.
  • In the last 5 years, Global Medical REIT's Revenue skyrocketed by 2813.87% in 2021 and then crashed by 921.34% in 2023.
  • Over the past 5 years, Global Medical REIT's Revenue (Quarter) stood at $30.3 million in 2021, then grew by 19.65% to $36.3 million in 2022, then dropped by 9.21% to $33.0 million in 2023, then grew by 6.66% to $35.2 million in 2024, then grew by 5.9% to $37.2 million in 2025.
  • Its Revenue stands at $37.2 million for Q3 2025, versus $38.0 million for Q2 2025 and $34.6 million for Q1 2025.